-
Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.
Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, Zhao P, Graham SF, Cool DR, Nicolaides K.
Sci Rep 2017;7:16189. pdf -
Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.
Mosimann B, Wagner M, Birdir C, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013;26:763-7. -
Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration.
Galazis N, Docheva N, Nicolaides KH, Atiomo W.
PLoS One 2013;8:e53801. -
C-reactive protein at 11-13 weeks' gestation in spontaneous early preterm delivery.
Bakalis SP, Poon LC, Vayna AM, Pafilis I, Nicolaides KH.
J Matern Fetal Neonatal Med 2012;25:2475-8. -
Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks?
Mastricci AL, Akolekar R, Kuppusamy R, Ahmed M, Nicolaides KH.
Fetal Diagn Ther 2011;30:53-9. -
First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.
Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:135-41. -
Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.
Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH.
BJOG 2002;109:297-301.